Cancer Institute A national cancer institute
designated cancer center

Ronald Levy, MD

Publication Details

  • Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Sagi, Y., Landrigan, A., Levy, R., Levy, S. 2012; 109 (5): 1613-1618

    Abstract:

    Cluster of differentiation 81 (CD81) is a widely expressed tetraspanin molecule that physically associates with CD4 and CD8 on the surface of human T cells. Coengagement of CD81 and CD3 results in the activation and proliferation of T cells. CD81 also costimulated mouse T cells that lack CD28, suggesting either a redundant or a different mechanism of action. Here we show that CD81 and CD28 have a preference for different subsets of T cells: Primary human naïve T cells are better costimulated by CD81, whereas the memory T-cell subsets and Tregs are better costimulated by CD28. The more efficient activation of naïve T cells by CD81 was due to prolonged signal transduction compared with that by CD28. We found that IL-6 played a role in the activation of the naïve T-cell subset by CD81. Combined costimulation through both CD28 and CD81 resulted in an additive effect on T-cell activation. Thus, these two costimulatory molecules complement each other both in the strength of signal transduction and in T-cell subset inclusions. Costimulation via CD81 might be useful for expansion of T cells for adoptive immunotherapy to allow the inclusion of naïve T cells with their broad repertoire.

    View details for DOI 10.1073/pnas.1121307109

    View details for Web of Science ID 000299731400056

    View details for PubMedID 22307619

Stanford Medicine Resources:

Footer Links: